Studies indicate that the downregulation of the mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3-kinase (PI3K)/protein kinase B (AKT) pathways contributes to melanoma progression [84]. Here, AKT1 is linked to melanoma.